NIAID Banner Logo Image

HIV Citations List: August, 2018

Literature Citations

1. Guanidine-containing Phenyl-pyrrole Compounds as Probes for Generating HIV Entry Inhibitors Targeted to gp120. Belov, D.S., F. Curreli, A.V. Kurkin, A. Altieri, and A.K. Debnath. ChemistrySelect, 2018. 3(23): p. 6450-6453. ISI[000435933100025].
[WOS]. HIV_08_2018.

2. Antitubercular and HIV-1 Enzyme Inhibitory Activities of South African Macrofungi. Boukes, G., J. Didloff, M. van de Venter, and S. Govender. FEBS Open Bio, 2018. 8: p. 284-284. ISI[000437674103239].
[WOS]. HIV_08_2018.

3. Extracting Functional Groups of Allini to Design Derivatives of FDA-approved Drugs: Inhibition of HIV-1 Integrase.Kalathiya, U., M. Padariya, and M. Baginski. Biotechnology and Applied Biochemistry, 2018. 65(4): p. 594-607. PMID[29405478].
[PubMed]. HIV_08_2018.

4. HIV-1 Env Trimer Conformational Implications of Peptide Fusion Inhibitor Resistance.Keller, P., O. Morrison, R. Vassell, and C. Weiss. Journal of Acquired Immune Deficiency Syndromes, 2018. 77: p. 59-59. ISI[000440562500084].
[WOS]. HIV_08_2018.

5. Design, Synthesis and anti-HIV-1 Activity of Modified Styrylquinolines. Mahajan, S., S. Gupta, N. Jariwala, D. Bhadane, L.K.K. Bhutani, S. Kulkarni, and I.P. Singh. Letters in Drug Design & Discovery, 2018. 15(9): p. 937-944. ISI[000438897300003].
[WOS]. HIV_08_2018.

6. Uvaria angolensis as a Promising Source of Inhibitors of HIV-1 Reverse Transcriptase Associated RNA-dependent DNA Polymerase and RNase H Functions. Ngoutane, A., A. Corona, E. Tramontano, F.F. Boyom, P. Caboni, and G. Tocco. Natural Product Research, 2018. 32(6): p. 640-647. PMID[28540745].
[PubMed]. HIV_08_2018.

7. Design and Synthesis of Selenazole-substituted Ritonavir Analogs. Qiao, J., C. Zhao, J. Liu, and Y. Du. Bioorganic & Medicinal Chemistry Letters. 28(14): p. 2379-2381. PMID[29934245].
[PubMed]. HIV_08_2018.

8. Synthesis of Potential HIV Integrase Inhibitors Inspired by Natural Polyphenol Structures. Righi, G., R. Pelagalli, V. Isoni, I. Tirotta, M. Marini, M. Palagri, R. Dallocchio, A. Dessi, B. Macchi, C. Frezza, G. Forte, A. Dalla Cort, G. Portalone, and P. Bovicelli. Natural Product Research, 2018. 32(16): p. 1893-1901. PMID[28748719].
[PubMed]. HIV_08_2018.

9. Synthesis of C-2 and C-3 Substituted Quinolines and Their Evaluation as anti-HIV-1 Agents. Shah, P., D. Naik, N. Jariwala, D. Bhadane, S. Kumar, S. Kulkarni, K.K. Bhutani, and I.P. Singh. Bioorganic Chemistry, 2018. 80: p. 591-601. PMID[30036815].
[PubMed]. HIV_08_2018.

10. In Vitro anti-HIV and Antioxidant Potential of Bulbine frutescens (Asphodelaceae). Shikalepo, R., C. Mukakalisa, M. Kandawa-Schulz, W. Chingwaru, and P. Kapewangolo. Journal of Herbal Medicine, 2018. 12: p. 73-78. ISI[000439896400008].
[WOS]. HIV_08_2018.

11. Rationally Designed Peptides as Efficient Inhibitors of Nucleic acid Chaperone Activity of HIV-1 Nucleocapsid Protein. Shvadchak, V., S. Zgheib, B. Basta, N. Humbert, J. Langedijk, M.C. Morris, S. Ciaco, O. Maskri, J.L. Darlix, O. Mauffret, P. Fosse, E. Real, and Y. Mely. Biochemistry, 2018. 57(30): p. 4562-4573. PMID[30019894].
[PubMed]. HIV_08_2018.

12. HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-resistant Mutants. Smith, S.J., X.Z. Zhao, T.R. Burke, Jr., and S.H. Hughes. Antimicrobial Agents and Chemotherapy. 62(9): p. e01035-18. PMID[29987149].
[PubMed]. HIV_08_2018.

13. Diversity-oriented Synthesis of Diol-based Peptidomimetics as Potential HIV Protease Inhibitors and Antitumor Agents. Vadhadiya, P.M., M.A. Jean, C. Bouzriba, T. Tremblay, P. Lague, S. Fortin, J. Boukouvalas, and D. Giguere. ChemBioChem, 2018. 19(16): p. 1779-1791. PMID[29858881].
[PubMed]. HIV_08_2018.

14. Structural Basis for Potent and Broad Inhibition of HIV-1 RT by Thiophene[3,2-d]pyrimidine Non-nucleoside Inhibitors. Yang, Y., D.W. Kang, L.A. Nguyen, Z.B. Smithline, C. Pannecouque, P. Zhan, X.Y. Liu, and T.A. Steitz. eLife, 2018. 7: p. e36340. PMID[30044217]. PMCID[PMC6080946].
[PubMed]. HIV_08_2018.

Patent Citations

15. Inhibitors of HIV-1 Integrase Multimerization for Treating HIV Infection. Andrake, M.D., A.M. Skalka, and G.W. Merkel. Patent. 2018. 2018-US15502 2018140762: 48pp.
[Patent]. HIV_08_2018.

16. Preparation of Azapeptide Atazanavir Analogs Useful for Treating HIV Infections. Bacon, E.M., E. Chin, J.J. Cottell, A.A. Katana, D. Kato, J.O. Link, N. Shapiro, T.A. Trejo Martin, and Z.-Y. Yang. Patent. 2018. 2018-US16893 2018145021: 395pp.
[Patent]. HIV_08_2018.

17. Herbal Microbicide Formulation for Preventing HIV. Polachira, S.K., R.N.R. Jayalekha, S.K. Gupta, N.N. Mishra, and A. Agarwal. Patent. 2018. 2018-IN50056 2018142428: 57pp.
[Patent]. HIV_08_2018.

Database last updated: September 2018